Literature DB >> 6431945

Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.

S G Mendoza, A Zerpa, H Carrasco, O Colmenares, A Rangel, P S Gartside, M L Kashyap.   

Abstract

A series of thirty-three Venezuelan men with premature myocardial infarction (mean age (M +/- SEM) 45 +/- 1.5 yrs) and with greater than 50% occlusion of at least 2 coronary arteries, and 19 weight matched control men (age 44 +/- 2 yrs) with normal coronary arteries on coronary angiography were studied. The percentages of significantly abnormal (greater than +/- 2 S.D. of controls) serum or plasma concentrations of various measurements (in decreasing order) were: estradiol (33%), total apolipoprotein (apo)B (24%), estradiol/testosterone ratio (21%), low density lipoprotein (LDL) apo B (19%), apo AI (17%), apo AI/total plasma apo B ratio (17%), total cholesterol (17%), and LDL-cholesterol (LDL-C) (11%). In addition, a multivariate discriminant function analysis showed that only estradiol, apo AI, LDL-C, estradiol/testosterone ratio and total cholesterol were statistically significant independent markers of myocardial infarction with occlusive coronary disease in these patients. Both serum estradiol and estradiol/testosterone ratio correlated positively with plasma apo B and LDL apo B, and inversely with apo AI; serum testosterone correlated inversely with plasma apo B (p less than 0.05). The data suggest that circulating sex hormones (estrogens, testosterone) are not only independent markers of coronary disease but may be pathogenetically linked to apo B and apo AI metabolism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6431945

Source DB:  PubMed          Journal:  Artery        ISSN: 0098-6127


  17 in total

1.  High-density lipoprotein cholesterol in diabetes: is higher always better?

Authors:  Tina Costacou; Rhobert W Evans; Trevor J Orchard
Journal:  J Clin Lipidol       Date:  2011-06-28       Impact factor: 4.766

2.  Systemic hypotensive effects of testosterone are androgen structure-specific and neuronal nitric oxide synthase-dependent.

Authors:  Mercedes Perusquía; Clayton D Greenway; Lisa M Perkins; John N Stallone
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-05-06       Impact factor: 3.619

Review 3.  Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men.

Authors:  C Cattabiani; S Basaria; G P Ceda; M Luci; A Vignali; F Lauretani; G Valenti; R Volpi; M Maggio
Journal:  J Endocrinol Invest       Date:  2011-11-08       Impact factor: 4.256

Review 4.  Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolites.

Authors:  Mercedes Perusquía; John N Stallone
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-12       Impact factor: 4.733

5.  CI-924 effects on plasma lipids in patients with type II and type IV hyperlipoproteinaemia.

Authors:  C N Corder; H U Kloer; M D Price
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  Physiological levels of estradiol correlate with lipid / lipoprotein profiles in healthy men.

Authors:  N Shono; Y Higaki; M Mori; M Nishizumi
Journal:  Environ Health Prev Med       Date:  1999-07       Impact factor: 3.674

7.  Subtype-specific estrogen receptor-mediated vasodilator activity in the cephalic, thoracic, and abdominal vasculature of female rat.

Authors:  Ossama M Reslan; Zongzhi Yin; Graciliano R A do Nascimento; Raouf A Khalil
Journal:  J Cardiovasc Pharmacol       Date:  2013-07       Impact factor: 3.105

8.  Relationship between lipoprotein lipase activity and plasma sex steroid level in obese women.

Authors:  P H Iverius; J D Brunzell
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

9.  Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  S S Soedamah-Muthu; Y-F Chang; J Otvos; R W Evans; T J Orchard
Journal:  Diabetologia       Date:  2003-05-13       Impact factor: 10.122

10.  Mechanism of action of gemfibrozil on lipoprotein metabolism.

Authors:  K Saku; P S Gartside; B A Hynd; M L Kashyap
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.